Work

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Year: 2014

Type: article

Source: American Heart Journal

DOI: 10.1016/j.ahj.2014.09.006

Authors: Christopher B. Granger, Renato D. Lopes, Michael Hanna, Jack Ansell, Elaine M. Hylek, John H. Alexander, Laine Thomas, Junyuan Wang, M. Cecilia Bahit, Freek Verheugt, Jack Lawrence, Denis Xavier, Lars Wallentin

Institutions: Duke Medical Center, Duke Clinical Research Institute, Bristol-Myers Squibb (United States), Lenox Hill Hospital, Boston University, Boston Medical Center, Instituto de Neurología Cognitiva, OLVG, St.John's Medical College Hospital, Uppsala University

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Duke Clinical Research Institute

OpenAlex ID: W2031640679

FWCI: 6.168

Cites: 11

Cited by: 71

Related to: 10